Duchenne Muscular Dystrophy Market in South Korea - Manufacturing and Consumption, Outlook and Forecast 2020-2026
uchenne muscular dystrophy is an x-linked genetic disorder that affects mostly boys. In Duchenne, boys begin to show signs of muscle weakness as early as two to five years of age. The disease gradually weakens the skeletal or voluntary muscles in the arms, legs and trunk. Due to progressive muscle weakness, Duchenne patients are often wheelchair bound between the ages of seven and 13 years old. At a later stage, the boys' respiratory and cardiac muscles are also affected and for most boys, respiratory and cardiac failure are major causes of death, often prevalent by the age of 20.
This report contains market size and forecasts of Duchenne Muscular Dystrophy in South Korea, including the following market information:
South Korea Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)
South Korea Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in South Korea Duchenne Muscular Dystrophy Market 2019 (%)
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in South Korea
Total Market by Segment:
South Korea Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
South Korea Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)
South Korea Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total South Korea Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
This report contains market size and forecasts of Duchenne Muscular Dystrophy in South Korea, including the following market information:
South Korea Duchenne Muscular Dystrophy Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Duchenne Muscular Dystrophy Market Consumption, 2015-2020, 2021-2026, (K Doses)
South Korea Duchenne Muscular Dystrophy Production Capacity, 2015-2020, 2021-2026, (K Doses)
Top Five Competitors in South Korea Duchenne Muscular Dystrophy Market 2019 (%)
The global Duchenne Muscular Dystrophy market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Duchenne Muscular Dystrophy market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Duchenne Muscular Dystrophy manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Duchenne Muscular Dystrophy production and consumption in South Korea
Total Market by Segment:
South Korea Duchenne Muscular Dystrophy Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Doses)
South Korea Duchenne Muscular Dystrophy Market Segment Percentages, By Type, 2019 (%)
- Deflazacort
- Prednisone
- Others
South Korea Duchenne Muscular Dystrophy Market Segment Percentages, By Application, 2019 (%)
- Male
- Female
The report also provides analysis of leading market participants including:
Total Duchenne Muscular Dystrophy Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Duchenne Muscular Dystrophy Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Duchenne Muscular Dystrophy Market Competitors Sales, by Players 2015-2020 (Estimated), (K Doses)
Total South Korea Duchenne Muscular Dystrophy Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
- PTC Therapeutics
- Sarepta Therapeutics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Duchenne Muscular Dystrophy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 South Korea Duchenne Muscular Dystrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: SOUTH KOREA DUCHENNE MUSCULAR DYSTROPHY OVERALL MARKET SIZE
2.1 South Korea Duchenne Muscular Dystrophy Market Size: 2020 VS 2026
2.2 South Korea Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Duchenne Muscular Dystrophy Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Duchenne Muscular Dystrophy Companies Ranked by Revenue
3.3 South Korea Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Duchenne Muscular Dystrophy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in South Korea
3.8.1 List of South Korea Tier 1 Duchenne Muscular Dystrophy Companies
3.8.2 List of South Korea Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - South Korea Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026
4.1.2 Deflazacort
4.1.3 Prednisone
4.1.4 Others
4.2 By Type - South Korea Duchenne Muscular Dystrophy Revenue & Forecasts
4.2.1 By Type - South Korea Duchenne Muscular Dystrophy Revenue, 2015-2020
4.2.2 By Type - South Korea Duchenne Muscular Dystrophy Revenue, 2021-2026
4.2.3 By Type - South Korea Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
4.3 By Type - South Korea Duchenne Muscular Dystrophy Sales & Forecasts
4.3.1 By Type - South Korea Duchenne Muscular Dystrophy Sales, 2015-2020
4.3.2 By Type - South Korea Duchenne Muscular Dystrophy Sales, 2021-2026
4.3.3 By Type - South Korea Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
4.4 By Type - South Korea Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - South Korea Duchenne Muscular Dystrophy Market Size, 2020 & 2026
5.1.2 Male
5.1.3 Female
5.2 By Application - South Korea Duchenne Muscular Dystrophy Revenue & Forecasts
5.2.1 By Application - South Korea Duchenne Muscular Dystrophy Revenue, 2015-2020
5.2.2 By Application - South Korea Duchenne Muscular Dystrophy Revenue, 2021-2026
5.2.3 By Application - South Korea Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
5.3 By Application - South Korea Duchenne Muscular Dystrophy Sales & Forecasts
5.3.1 By Application - South Korea Duchenne Muscular Dystrophy Sales, 2015-2020
5.3.2 By Application - South Korea Duchenne Muscular Dystrophy Sales, 2021-2026
5.3.3 By Application - South Korea Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
5.4 By Application - South Korea Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 PTC Therapeutics
6.1.1 PTC Therapeutics Corporate Summary
6.1.2 PTC Therapeutics Business Overview
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.1.4 PTC Therapeutics Sales and Revenue in South Korea (2015-2020)
6.1.5 PTC Therapeutics Key News
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporate Summary
6.2.2 Sarepta Therapeutics Business Overview
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.2.4 Sarepta Therapeutics Sales and Revenue in South Korea (2015-2020)
6.2.5 Sarepta Therapeutics Key News
6.3 Others
6.3.1 Others Corporate Summary
6.3.2 Others Business Overview
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings
6.3.4 Others Sales and Revenue in South Korea (2015-2020)
6.3.5 Others Key News
7 DUCHENNE MUSCULAR DYSTROPHY PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
7.1.1 South Korea Duchenne Muscular Dystrophy Production Capacity, 2015-2026
7.1.2 South Korea Duchenne Muscular Dystrophy Production 2015-2026
7.1.3 South Korea Duchenne Muscular Dystrophy Production Value 2015-2026
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in South Korea
7.2.1 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity
7.2.2 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production
7.2.3 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production Value
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Duchenne Muscular Dystrophy Export and Import in South Korea
7.3.1 South Korea Duchenne Muscular Dystrophy Export Market
7.3.2 South Korea Duchenne Muscular Dystrophy Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for South Korea Duchenne Muscular Dystrophy Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DUCHENNE MUSCULAR DYSTROPHY SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in South Korea
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
1.1 Duchenne Muscular Dystrophy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 South Korea Duchenne Muscular Dystrophy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 COVID-19 IMPACT: SOUTH KOREA DUCHENNE MUSCULAR DYSTROPHY OVERALL MARKET SIZE
2.1 South Korea Duchenne Muscular Dystrophy Market Size: 2020 VS 2026
2.2 South Korea Duchenne Muscular Dystrophy Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Duchenne Muscular Dystrophy Sales (Consumption): 2015-2026
3 COMPANY LANDSCAPE
3.1 Top Duchenne Muscular Dystrophy Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Duchenne Muscular Dystrophy Companies Ranked by Revenue
3.3 South Korea Duchenne Muscular Dystrophy Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Duchenne Muscular Dystrophy Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Duchenne Muscular Dystrophy Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Duchenne Muscular Dystrophy Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Duchenne Muscular Dystrophy Product Type
3.8 Tier 1, Tier 2 and Tier 3 Duchenne Muscular Dystrophy Players in South Korea
3.8.1 List of South Korea Tier 1 Duchenne Muscular Dystrophy Companies
3.8.2 List of South Korea Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - South Korea Duchenne Muscular Dystrophy Market Size Markets, 2020 & 2026
4.1.2 Deflazacort
4.1.3 Prednisone
4.1.4 Others
4.2 By Type - South Korea Duchenne Muscular Dystrophy Revenue & Forecasts
4.2.1 By Type - South Korea Duchenne Muscular Dystrophy Revenue, 2015-2020
4.2.2 By Type - South Korea Duchenne Muscular Dystrophy Revenue, 2021-2026
4.2.3 By Type - South Korea Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
4.3 By Type - South Korea Duchenne Muscular Dystrophy Sales & Forecasts
4.3.1 By Type - South Korea Duchenne Muscular Dystrophy Sales, 2015-2020
4.3.2 By Type - South Korea Duchenne Muscular Dystrophy Sales, 2021-2026
4.3.3 By Type - South Korea Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
4.4 By Type - South Korea Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - South Korea Duchenne Muscular Dystrophy Market Size, 2020 & 2026
5.1.2 Male
5.1.3 Female
5.2 By Application - South Korea Duchenne Muscular Dystrophy Revenue & Forecasts
5.2.1 By Application - South Korea Duchenne Muscular Dystrophy Revenue, 2015-2020
5.2.2 By Application - South Korea Duchenne Muscular Dystrophy Revenue, 2021-2026
5.2.3 By Application - South Korea Duchenne Muscular Dystrophy Revenue Market Share, 2015-2026
5.3 By Application - South Korea Duchenne Muscular Dystrophy Sales & Forecasts
5.3.1 By Application - South Korea Duchenne Muscular Dystrophy Sales, 2015-2020
5.3.2 By Application - South Korea Duchenne Muscular Dystrophy Sales, 2021-2026
5.3.3 By Application - South Korea Duchenne Muscular Dystrophy Sales Market Share, 2015-2026
5.4 By Application - South Korea Duchenne Muscular Dystrophy Price (Manufacturers Selling Prices), 2015-2026
6 MANUFACTURERS & BRANDS PROFILES
6.1 PTC Therapeutics
6.1.1 PTC Therapeutics Corporate Summary
6.1.2 PTC Therapeutics Business Overview
6.1.3 PTC Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.1.4 PTC Therapeutics Sales and Revenue in South Korea (2015-2020)
6.1.5 PTC Therapeutics Key News
6.2 Sarepta Therapeutics
6.2.1 Sarepta Therapeutics Corporate Summary
6.2.2 Sarepta Therapeutics Business Overview
6.2.3 Sarepta Therapeutics Duchenne Muscular Dystrophy Major Product Offerings
6.2.4 Sarepta Therapeutics Sales and Revenue in South Korea (2015-2020)
6.2.5 Sarepta Therapeutics Key News
6.3 Others
6.3.1 Others Corporate Summary
6.3.2 Others Business Overview
6.3.3 Others Duchenne Muscular Dystrophy Major Product Offerings
6.3.4 Others Sales and Revenue in South Korea (2015-2020)
6.3.5 Others Key News
7 DUCHENNE MUSCULAR DYSTROPHY PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS
7.1 Duchenne Muscular Dystrophy Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
7.1.1 South Korea Duchenne Muscular Dystrophy Production Capacity, 2015-2026
7.1.2 South Korea Duchenne Muscular Dystrophy Production 2015-2026
7.1.3 South Korea Duchenne Muscular Dystrophy Production Value 2015-2026
7.2 Key Local Duchenne Muscular Dystrophy Manufacturers in South Korea
7.2.1 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production Capacity
7.2.2 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production
7.2.3 South Korea Key Local Duchenne Muscular Dystrophy Manufacturers Production Value
7.2.4 The Proportion of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Duchenne Muscular Dystrophy Export and Import in South Korea
7.3.1 South Korea Duchenne Muscular Dystrophy Export Market
7.3.2 South Korea Duchenne Muscular Dystrophy Source of Imports
8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
8.1 PESTLE Analysis for South Korea Duchenne Muscular Dystrophy Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints
9 COVID-19 IMPACT ON DUCHENNE MUSCULAR DYSTROPHY SUPPLY CHAIN ANALYSIS
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Duchenne Muscular Dystrophy Distributors and Sales Agents in South Korea
10 CONCLUSION
11 APPENDIX
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Duchenne Muscular Dystrophy in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020
Table 5. South Korea Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020
Table 6. South Korea Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)
Table 8. South Korea Manufacturers Duchenne Muscular Dystrophy Product Type
Table 9. List of South Korea Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Duchenne Muscular Dystrophy Sales in South Korea (K Doses), 2015-2020
Table 14. By Type - Duchenne Muscular Dystrophy Sales in South Korea (K Doses), 2021-2026
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Duchenne Muscular Dystrophy Sales in South Korea, (K Doses), 2015-2020
Table 18. By Application - Duchenne Muscular Dystrophy Sales in South Korea, (K Doses), 2021-2026
Table 19. PTC Therapeutics Corporate Summary
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Sarepta Therapeutics Corporate Summary
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Others Corporate Summary
Table 26. Others Duchenne Muscular Dystrophy Product Offerings
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in South Korea, 2015-2020
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in South Korea, 2015-2020
Table 30. South Korea Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 32. South Korea Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020
Table 36. Raw Materials and Suppliers
Table 37. Duchenne Muscular Dystrophy Downstream Clients in South Korea
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in South Korea
Table 1. Key Players of Duchenne Muscular Dystrophy in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Duchenne Muscular Dystrophy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Duchenne Muscular Dystrophy Revenue Share by Companies, 2015-2020
Table 5. South Korea Duchenne Muscular Dystrophy Sales by Companies, (K Doses), 2015-2020
Table 6. South Korea Duchenne Muscular Dystrophy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Duchenne Muscular Dystrophy Price (2015-2020) (USD/Dose)
Table 8. South Korea Manufacturers Duchenne Muscular Dystrophy Product Type
Table 9. List of South Korea Tier 1 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Duchenne Muscular Dystrophy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Duchenne Muscular Dystrophy Sales in South Korea (K Doses), 2015-2020
Table 14. By Type - Duchenne Muscular Dystrophy Sales in South Korea (K Doses), 2021-2026
Table 15. By Application - Duchenne Muscular Dystrophy Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Duchenne Muscular Dystrophy Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Duchenne Muscular Dystrophy Sales in South Korea, (K Doses), 2015-2020
Table 18. By Application - Duchenne Muscular Dystrophy Sales in South Korea, (K Doses), 2021-2026
Table 19. PTC Therapeutics Corporate Summary
Table 20. PTC Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 21. PTC Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 22. Sarepta Therapeutics Corporate Summary
Table 23. Sarepta Therapeutics Duchenne Muscular Dystrophy Product Offerings
Table 24. Sarepta Therapeutics Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 25. Others Corporate Summary
Table 26. Others Duchenne Muscular Dystrophy Product Offerings
Table 27. Others Duchenne Muscular Dystrophy Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2015-2020)
Table 28. Duchenne Muscular Dystrophy Production Capacity (K Doses) of Local Manufacturers in South Korea, 2015-2020
Table 29. Duchenne Muscular Dystrophy Production (K Doses) of Local Manufacturers in South Korea, 2015-2020
Table 30. South Korea Duchenne Muscular Dystrophy Production Market Share of Local Manufacturers, 2015-2020
Table 31. Duchenne Muscular Dystrophy Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 32. South Korea Duchenne Muscular Dystrophy Production Value Market Share of Local Manufacturers, 2015-2020
Table 33. The Percentage of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 34. The Percentage of Duchenne Muscular Dystrophy Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 35. Dangeguojia Duchenne Muscular Dystrophy Sales (Consumption), Production, Export and Import, 2015-2020
Table 36. Raw Materials and Suppliers
Table 37. Duchenne Muscular Dystrophy Downstream Clients in South Korea
Table 38. Duchenne Muscular Dystrophy Distributors and Sales Agents in South Korea
LIST OF FIGURES
Figure 1. Duchenne Muscular Dystrophy Segment by Type
Figure 2. Duchenne Muscular Dystrophy Segment by Application
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Duchenne Muscular Dystrophy Market Size in South Korea, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. South Korea Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)
Figure 7. Duchenne Muscular Dystrophy Sales in South Korea: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 9. By Type - South Korea Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 11. By Type - South Korea Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 12. By Type - South Korea Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 15. By Application - South Korea Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 16. By Application -South Korea Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 17. South Korea Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026
Figure 18. South Korea Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026
Figure 19. South Korea Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Duchenne Muscular Dystrophy Export Destination, 2019
Figure 21. The Source of Imports of South Korea Duchenne Muscular Dystrophy, 2019
Figure 22. PEST Analysis for South Korea Duchenne Muscular Dystrophy Market in 2020
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in South Korea
Figure 24. Duchenne Muscular Dystrophy Market Drivers in South Korea
Figure 25. Duchenne Muscular Dystrophy Market Restraints in South Korea
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain
Figure 1. Duchenne Muscular Dystrophy Segment by Type
Figure 2. Duchenne Muscular Dystrophy Segment by Application
Figure 3. Dangeguojia Duchenne Muscular Dystrophy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Duchenne Muscular Dystrophy Market Size in South Korea, (US$, Mn) & (K Doses): 2020 VS 2026
Figure 6. South Korea Duchenne Muscular Dystrophy Revenue, 2015-2026 (US$, Mn)
Figure 7. Duchenne Muscular Dystrophy Sales in South Korea: 2015-2026 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Duchenne Muscular Dystrophy Revenue in 2019
Figure 9. By Type - South Korea Duchenne Muscular Dystrophy Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 11. By Type - South Korea Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 12. By Type - South Korea Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 13. By Application - Duchenne Muscular Dystrophy Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Duchenne Muscular Dystrophy Market Share, 2015-2020
Figure 15. By Application - South Korea Duchenne Muscular Dystrophy Market Share, 2020-2026
Figure 16. By Application -South Korea Duchenne Muscular Dystrophy Price (USD/Dose), 2015-2026
Figure 17. South Korea Duchenne Muscular Dystrophy Production Capacity (K Doses), 2015-2026
Figure 18. South Korea Duchenne Muscular Dystrophy Actual Output (K Doses), 2015-2026
Figure 19. South Korea Duchenne Muscular Dystrophy Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Duchenne Muscular Dystrophy Export Destination, 2019
Figure 21. The Source of Imports of South Korea Duchenne Muscular Dystrophy, 2019
Figure 22. PEST Analysis for South Korea Duchenne Muscular Dystrophy Market in 2020
Figure 23. Duchenne Muscular Dystrophy Market Opportunities & Trends in South Korea
Figure 24. Duchenne Muscular Dystrophy Market Drivers in South Korea
Figure 25. Duchenne Muscular Dystrophy Market Restraints in South Korea
Figure 26. Duchenne Muscular Dystrophy Industry Value Chain
